Company MustGrow Biologics Corp. Canadian Securities Exchange

Equities

MGRO

CA62822A1030

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		+6.74%	-28.57%

Apr. 23	MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 22	MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index	CI

MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The Company is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The Company is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.

CAD in Million	2022	Weight	2023	Weight	Delta
Natural Biopesticide 100.0 %	0	100.0 %	5	100.0 %	+72,630.36%

CAD in Million	2022	Weight	2023	Weight	Delta
Germany 86.4 %	-	-	4	86.4 %	-
Japan 13.6 %	-	-	1	13.6 %	-

Managers	Title	Age	Since
Corey Giasson CEO	Chief Executive Officer	46	18-03-14
Todd Lahti DFI	Director of Finance/CFO	58	18-12-16
Colin Bletsky COO	Chief Operating Officer	49	18-03-14

Members of the board	Title	Age	Since
Brian Quigley BRD	Director/Board Member	50	19-07-16
Brad Munro CHM	Chairman	64	18-03-14
Corey Giasson CEO	Chief Executive Officer	46	18-03-14
Thomas Flow BRD	Director/Board Member	47	18-05-30
Colin Bletsky COO	Chief Operating Officer	49	18-03-14
Matt Kowalski BRD	Director/Board Member	-	18-05-30
Laura Westby BRD	Director/Board Member	-	22-03-14
David Borecky BRD	Director/Board Member	-	20-12-13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	51,463,575	44,368,134 ( 86.21 %)	0	86.21 %

Name	Equities	%	Valuation
Corey Giasson 3.586 %	1,795,643	3.586 %	2 M $
Colin Bletsky 3.513 %	1,759,013	3.513 %	2 M $
Brad Munro 1.104 %	553,026	1.104 %	507 678 $
Todd Lahti 0.8558 %	428,572	0.8558 %	393 429 $
Brian Quigley 0.7968 %	399,000	0.7968 %	366 282 $
Thomas Flow 0.5316 %	266,200	0.5316 %	244 372 $
Matt Kowalski 0.4075 %	204,044	0.4075 %	187 312 $
Laura Westby 0.000000 %	0	0.000000 %	- $
David Borecky 0.000000 %	0	0.000000 %	- $

MustGrow Biologics Corp.

201 1st Avenue South Suite 1005

S7K 1J5, Saskatoon

+306-668-2652

http://www.mustgrow.ca

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research